降压饮对高血压肝阳上亢证患者生活质量影响的临床研究

来源 :实用中医内科杂志 | 被引量 : 0次 | 上传用户:zaizhen
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
[目的]观察降压饮对高血压肝阳上亢证患者的降压疗效以及生活质量的改善情况。[方法]将120例高血压患者随机分为两组。西药对照组使用在治疗前已应用的ACEI、钙离子阻滞剂,不允许用其他对血压有影响的药物,中药联合治疗组是在此基础上加用中药降压饮。疗程为4周。观察患者血压、中医症状及生活质量变化。[结果]中药联合治疗组降压效果优于西药对照组,中医症状优于西药对照组,生活质量的改善也明显优于西药对照组,两组比较差异有统计学意义(P<0.05)。[结论]降压饮对高血压肝阳上亢证患者有较好的降压疗效,能明显改善患者的临床症状,提高患者生活质量。 [Objective] To observe the antihypertensive effects of antihypertensive drink on hypertensive patients with liver-Yang hyperactivity and the improvement of quality of life. [Methods] 120 cases of hypertension were randomly divided into two groups. Western medicine control group used before treatment has been applied ACEI, calcium blockers, does not allow other drugs that affect blood pressure, Chinese medicine combined treatment group is based on the use of Chinese medicine antihypertensive drink. Treatment for 4 weeks. Observe the patient’s blood pressure, TCM symptoms and quality of life changes. [Result] The antihypertensive effect of combination therapy group was better than western medicine control group. The symptoms of traditional Chinese medicine were superior to western medicine control group, and the improvement of quality of life was also better than western medicine control group. There was significant difference between the two groups (P <0.05). [Conclusion] Antihypertensive drink has a good antihypertensive effect on hypertensive patients with liver-yang hyperactivity, which can significantly improve the clinical symptoms and improve the quality of life of patients.
其他文献
期刊
工程机械行业一季度的销售数据显示,产品市场销量出现不同幅度回升,甚至有厂家要加班生产以便按时交货。这突如其来的暖风给处于寒冬的工程机械行业带来了些许暖意。是经历多
期刊
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥
目的 动态观察实验小猪急性心肌梗死(Acute Myocardial Infarction,AMI)后心肌梗死部位的缺血区心肌细胞凋亡及Caspase-3蛋白的表达,探讨AMI后心肌细胞的凋亡机制.方法 将8只
射阳县地处苏北盐阜平原黄海之滨,是江苏全省公路网的末梢,尤其是乡村公路几乎是一张白纸.1994年县委、县政府认识到:要得富,修公路,小路小富,大路大富,无路不富.于是制订了,
期刊
目的 探讨基质细胞衍生因子SDF-1α及其受体CXCR4在类风湿关节炎(RA)发生、发展中的作用及意义.方法 用流式细胞术对50例RA患者和25例健康志愿者外周血CD3+ CD4+T细胞、CD3+
期刊
期刊